__NUXT_JSONP__("/drugs/Urelumab", (function(a,b,c){return {data:[{drug:{slug:a,emaEpar:[],fdaDrugLabel:[],id:a,nciThesaurus:{casRegistry:"934823-49-1",chebiId:b,chemicalFormula:b,definition:"A fully human agonistic monoclonal antibody targeting the CD137 receptor with potential immunostimulatory and antineoplastic activities. Anti-CD137 monoclonal antibody specifically binds to and activates CD137-expressing immune cells, stimulating an immune response, in particular a cytotoxic T cell response, against tumor cells. CD137 is a member of the tumor necrosis factor (TNF)\u002Fnerve growth factor (NGF) family of receptors and is expressed by activated T- and B-lymphocytes and monocytes; its ligand has been found to play an important role in the regulation of immune responses.",fdaUniiCode:"230902QLLC",identifier:"C62449",preferredName:a,semanticType:"Amino Acid, Peptide, or Protein",subclassOf:["C155745"],synonyms:["BMS-663513","Immunoglobulin G4, Anti-(Human Receptor 4-1BB) (Human Gamma-Chain), Disulfide with Human Kappa-Chain, Dimer","URELUMAB",a]},dir:"\u002Fdrugs",path:"\u002Fdrugs\u002FUrelumab",extension:".json",createdAt:c,updatedAt:c}}],fetch:{},mutations:void 0}}("Urelumab","","2021-10-30T13:42:04.433Z")));